Board Meeting Intimation for Results & Resignation of Director
Nath Bio-Genes (India) Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on October 27, 2016, to take on record Unaudited financial results for the quarter ended September 30, 2016.Further, Mr. Pramod Kumar Gupta nominee director is resigned with the immediate effect. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Nath Bio-Genes (India) Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Corporate Presentation for June 30, 2016
Nath Bio-Genes (India) Ltd has informed BSE about Corporate Presentation for the period ended June 30, 2016. Intimation of Schedule of Analyst / Institutional Investor Meetings
Nath Bio-Genes (India) Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings". Shareholding for the Period Ended June 30, 2016
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Declaration of Postal Ballot Result
Nath Bio-Genes (India) Ltd has informed BSE regarding Declaration of Postal Ballot Result. Standalone Financial Results, Limited Review Report for June 30, 2016
Nath Bio-Genes (India) Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 2016 Scrutinizers Report
Nath Bio-Genes (India) Ltd has submitted to BSE a copy of the Scrutinizers report for the Annual General Meeting of the Company held on July 28, 2016. Standalone Financial Results for June 30, 2016
Nath Bio-Genes (India) Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 2016 Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Nath Bio-Genes (India) Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.